Binding of tissue plasminogen activator to human aortic endothelial cells
- 15 July 1990
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 269 (2) , 475-482
- https://doi.org/10.1042/bj2690475
Abstract
The experiments described in this paper were designed to examine the specific binding of tissue plasminogen activator (tPA) to cultured human aortic endothelial (HAE) cells. When 125I-labelled tPA was incubated with the cells at 4 degrees C, binding was found to plateau within 90 min after incubations were begun. Binding was saturable and the bound enzyme dissociated from the sites with a half-time of approx. 48 min. Scatchard analyses were performed using tPA molecules isolated from human melanoma and colon cells as well as from C127 and Chinese hamster ovary cells that had been transfected with the human tPA gene. These enzymes showed very similar binding characteristics in spite of the fact that they differ substantially in the types of sugars which comprise their side chains. Neither the chainedness of the molecules (one-chain or two-chain) nor the sites at which they are glycosylated (type I or type II) appear to affect their ability to interact with binding sites. The tPA molecules were found to have an average equilibrium dissociation constant of (1.15 +/- 0.10) x 10(-9) M and HAE cells appeared to have a single, homogeneous population of independent binding sites present at a concentration of (1.57 +/- 0.13) x 10(6) sites per cell. Lowering the pH of the binding buffer from 7.4 to 6.5 resulted in a reversible increase in specific binding of between 2-fold and 7-fold depending upon the particular preparation of cells. Preincubation of tPA with plasminogen activator inhibitor 1 (PAI-1) was found to have little effect on binding, suggesting that tPA interacts at sites distinct from surface-bound PAI-1. No evidence for either internalization or degradation of tPA was observed in assays run at 37 degrees C. This suggests that, like urokinase, tPA remains on cell surfaces for an extended period of time.This publication has 35 references indexed in Scilit:
- Cell-type-specific and site-specific N-glycosylation of type I and type II human tissue plasminogen activatorBiochemistry, 1989
- Characterization of the receptor for protease nexin-I: Protease complexes on human fibroblastsJournal of Cellular Physiology, 1987
- Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitorsThe Journal of cell biology, 1987
- Role of lipoproteins in growth of human adult arterial endothelial and smooth muscle cells in low lipoprotein‐deficient serumJournal of Cellular Physiology, 1986
- A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.The Journal of cell biology, 1985
- Tissue plasminogen activator: peptide analyses confirm an indirectly derived amino acid sequence, identify the active site serine residue, establish glycosylation sites, and localize variant differencesBiochemistry, 1984
- Tissue Plasminogen Activator: Chemical and Physiological AspectsSeminars in Thrombosis and Hemostasis, 1984
- ENDOTHELIAL CELL RECEPTORS FOR HISTAMINE*Annals of the New York Academy of Sciences, 1982
- Isolation of two variants of native one‐chain tissue plasminogen activatorFEBS Letters, 1982
- Studies on the kinetics of plasminogen activation by tissue plasminogen activatorBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1982